Search results for: 'drug ad daa0'

The geospatial value-added services market is seeing an influx of new participants owing to cheaper satellite data products and services and enabling information and communication technologies. Established incumbents have to compete with not only these participants but also new customer groups arising from the evolution of new use cases. The marke...

Autonomous driving and ADAS features are on the rise in the NA market. Market participants that offer vehicles with L1 and L2 capabilities dominate the current market. A few of these OEMs also have vehicles with L2+ capabilities. Vehicles with L2+ ADAS and L3 AD capabilities will dominate the future of the NA ADAS and AD markets. Because of the ple...

This research service explores the market for drug delivery used for the treatment of ocular diseases in the Unites States of America. It analyzes the various challenges faced by pharmaceutical, biotech, and drug delivery companies, and the competitive advantages and disadvantages of their products in the market.

The Frost Radar™ for the demand-side platform (DSP) market assesses providers offering software solutions that enable advertisers and agencies to plan, buy, measure, execute, and optimize their global advertising initiatives. These platforms act as advertising demand aggregators that permit the acquisition of ad inventory from media supply sources,...

The automotive industry is among the most affected by the COVID-19 pandemic and the ongoing semiconductor shortage. The resulting economic crisis impacted overall vehicle sales, leading to a delay in value chain components supply and technology introduction and a shift in consumer preferences. Original equipment manufacturers (OEMs) and value ch...

17 Mar 2015  |  Global  |  Market Research

Analysis of the Global Diabetes Drug Delivery Market

Future Options for End Users

Infographics

×

The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...

As the industry continues its innovation spree across novel small and large molecule therapies, such as RNA targeted small molecules, cell and gene therapies (CGT), and mRNA therapies, it is imperative for pharma sponsors to pursue partnerships to gain technology access, database generation and analysis, and pre-clinical and clinical research. Furt...

24 Feb 2015  |  Asia Pacific  |  Market Research

Analysis of the Global Oncology Drug Delivery Market

Future Impact of Emerging Technologies

Infographics

×

The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...